← Back to Search

NA

Vascular Assessment for Peripheral Arterial Disease

N/A
Waitlist Available
Led By Joshua Beckman, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion/
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is testing whether two types of vessel abnormalities working together cause worse leg function and walking.

Eligible Conditions
  • Peripheral Arterial Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Peripheral Artery Disease (PAD) with Supervised ExerciseExperimental Treatment2 Interventions
Subjects will be referred for supervised exercise therapy. Subjects will have 3 visits per week for 12 weeks. Each visit will include a minimum of 30 to 40 minutes of exercise to improve ambulation with a certified trainer.
Group II: Healthy SubjectsExperimental Treatment1 Intervention
Group III: PAD Subjects Who Undergo Revascularization of the LegActive Control1 Intervention
This group of subjects are receiving leg revascularization as part of standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vascular Assessment
2018
N/A
~80
Supervised Exercise
2017
Completed Phase 1
~340

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
888 Previous Clinical Trials
934,854 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
442 Patients Enrolled for Peripheral Arterial Disease
American Heart AssociationOTHER
343 Previous Clinical Trials
4,971,518 Total Patients Enrolled
10 Trials studying Peripheral Arterial Disease
778 Patients Enrolled for Peripheral Arterial Disease
Joshua Beckman, MDPrincipal Investigator - Vanderbilt University Medical Center
Vanderbilt University Medical Center
New York University School Of Medicine (Medical School)
Ny And Presby Hospital (Residency)
3 Previous Clinical Trials
117 Total Patients Enrolled
~11 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top